• SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin

  2026-07-01

  This study uncovers SEMA3E as a key regulator of beige adipocyte differentiation and thermogenesis in mice, acting through the Wnt/β-catenin signaling pathway. The findings provide mechanistic insight into adipose tissue remodeling and open new avenues for metabolic disorder research.

• Forskolin as an Adenylate Cyclase Activator: Applied Workflo

  2026-07-01

  Forskolin uniquely empowers precise cAMP pathway modulation in stem cell, neuroendocrine, and cardiovascular experimental models. Its direct adenylate cyclase activation streamlines reproducible workflows and enables translational insights not achievable with indirect cAMP agonists.

• RSV NS3 Modulates Host Signaling to Orchestrate Pathogenicit

  2026-06-30

  Zhuang et al. reveal how rice stripe virus (RSV) fine-tunes its pathogenicity and transmission by exploiting host kinase signaling pathways. The study demonstrates that through dynamic phosphorylation and protein-protein interactions, RSV NS3 manipulates host stress and immune responses, highlighting a cosurvival strategy with implications for broader viral-host coevolution.

• Empowering Assay Reliability with PYR-41, Inhibitor of Ubiqu

  2026-06-30

  This article provides scenario-driven guidance for utilizing PYR-41, inhibitor of Ubiquitin-Activating Enzyme (E1) (SKU B1492), to address common laboratory challenges in cell viability, proliferation, and cytotoxicity assays. We examine evidence-backed protocols, data interpretation pitfalls, and cross-compare vendor reliability, equipping biomedical researchers with practical insights for robust ubiquitination research.

• Lactylation-Driven KRT19 Bypasses Senescence in NSCLC Progre

  2026-06-29

  Zhang et al. uncover how lactate-induced histone H3K18 lactylation upregulates KRT19, enabling non-small cell lung cancer (NSCLC) cells to evade senescence via p21 suppression and promoting tumor progression. Their mechanistic insights reveal KRT19 as a promising target for synergistic NSCLC therapies, particularly in combination with immune checkpoint blockade.

• A40926 as a Dalbavancin Precursor: Workflows and Innovations

  2026-06-29

  A40926 empowers antibiotic discovery with robust, validated protocols for Gram-positive and multidrug-resistant bacteria, outpacing legacy glycopeptides. Its role as a dalbavancin precursor and potent bacterial cell wall synthesis inhibitor makes it a cornerstone for advanced in vitro and in vivo research.

• Naftifine HCl in Experimental Antifungal Workflows: Applied

  2026-06-28

  Naftifine HCl, a potent allylamine antifungal agent, enables precision studies of fungal membrane disruption and sterol biosynthesis. This guide delivers actionable protocols, advanced use-cases, and troubleshooting strategies to maximize its impact in topical antifungal research and mycology signaling assays.

• Calcitriol (SKU B2141): Data-Backed Solutions for Cell Assay

  2026-06-27

  This article addresses laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Calcitriol (SKU B2141) from APExBIO provides reproducible, quantitatively validated solutions. Scenario-driven Q&A blocks integrate the latest research on vitamin D receptor signaling and immune modulation, offering actionable guidance for experimental design, protocol optimization, and data interpretation.

• Ciprofloxacin: Mechanisms, Resistance Modeling, and Translat

  2026-06-26

  This article provides a thought-leadership perspective for translational researchers, exploring how Ciprofloxacin enables state-of-the-art modeling of fluoroquinolone antibiotic resistance. Grounded in mechanistic and epidemiological evidence, including the latest multicenter data from Guangdong, this piece connects molecular insight with strategic guidance and workflow optimizations, highlighting the unique value proposition of high-purity Ciprofloxacin from APExBIO.

• Lipo3K Transfection Reagent: Precision Tools for Cellular Me

  2026-06-26

  Explore how Lipo3K Transfection Reagent empowers high-efficiency transfection of challenging cell types for advanced gene expression and RNA interference studies. This article uniquely connects molecular evolution insights to practical assay design decisions.

• Mavorixafor in WHIM Syndrome: Phase 3 Advances and Translati

  2026-06-25

  The referenced phase 3 trial establishes mavorixafor, an oral CXCR4 antagonist, as a significant advance for WHIM syndrome by increasing neutrophil and lymphocyte counts and reducing infection rates. These results highlight targeted CXCR4 inhibition as a promising precision approach for rare immunodeficiencies, with implications for future translational research and protocol design.

• 40-Hz Light Flicker Promotes Retinal Amyloid Clearance via M

  2026-06-25

  This study demonstrates that 40-Hz light flicker enhances the clearance of retinal amyloid-β deposits in aged mice by upregulating MHC-II+ microglia activity. The findings suggest a non-invasive strategy for metabolic waste removal in age-related retinal disease and clarify the mechanistic role of microglial activation, with minocycline hydrochloride serving as a crucial tool for dissecting these pathways.

• Dinaciclib Exploits VHL Deficiency in Clear Cell Renal Cance

  2026-06-24

  The referenced study establishes that Dinaciclib, a cyclin-dependent kinase inhibitor, selectively induces cell death in VHL-deficient clear cell renal cell carcinoma (CC-RCC) through synthetic lethality. This mechanistic insight provides a rationale for targeted therapies that spare normal and VHL-restored cells, addressing a critical unmet need in metastatic kidney cancer.

• GPNMB-Based Multimodal Model Predicts ESCC Immunotherapy Res

  2026-06-23

  This study introduces a clinically validated model integrating circulating GPNMB levels, CAF-Epi niche features, and clinical-pathological data to robustly predict immunotherapy response in esophageal squamous cell carcinoma (ESCC). The findings clarify how tumor-derived soluble GPNMB drives CD8+ T cell exhaustion, advancing precision strategies for patient selection in ESCC immunotherapy.

• Ca2+-Dependent Autophagy and Lysosomal Alkalinization in GBM

  2026-06-23

  This study demonstrates that the tetralin derivative NNC-55–0396 induces cytotoxicity in glioblastoma cells via a dual mechanism: stimulating Ca2+-driven autophagy and simultaneously blocking autophagic flux through lysosomal alkalinization. The findings clarify how perturbation of calcium signaling and autophagy interplay contributes to tumor cell death, offering new mechanistic perspectives for targeting resistant glioblastoma.

455 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page